出海

Search documents
优质赛道穿越周期,机器人转型星辰大海——零部件行业2025年度中期投资策略
2025-07-11 01:05
优质赛道穿越周期,机器人转型星辰大海——零部件行业 2025 年度中期投资策略 20250710 摘要 智能化赛道迎来快速增长,激光雷达市场预计从 2024 年的 40 亿增长 到 2028 年的 120 亿,芯片市场可能从 200 亿以上增长到 500 亿以上, 线控制动系统有望从 150 亿增长到 260 亿以上,受益于消费者购车重 点转向智能化因素,智能化渗透率正处于快速爆发期。 科技化领域如座椅、车灯和玻璃等赛道,虽然没有爆发性增长,但由于 配置力度提升,ASP 持续上升。座椅功能增加,车灯升级为 ADB 和 DLP 大灯,玻璃产品如镀膜天幕和调光天幕的应用,使得单车价显著增 加,例如小米调光天幕价格可达到 3,000 元。 中国零部件厂商在欧美日韩国家的出海更加顺利,在墨西哥建厂后接订 单情况良好,利润率表现优异。海外市场空间约为国内的三倍,受贸易 战影响,中国企业更多地选择从墨西哥或其他地区出口,整体出海业务 持续增长。 人形机器人产业蓬勃发展,未来三到五年迎来量级释放,中国汽车零部 件企业开始向机器人领域转移,有望打开第二增长曲线。机器人成本下 降,技术迭代显著,但 ToB 端应用发展较慢,未来 ...
优爱腾芒(剧):国内打的火热,国外呢?
3 6 Ke· 2025-07-11 00:53
Group 1 - The summer season has initiated a competitive landscape among major streaming platforms in China, including iQIYI, Tencent Video, Youku, and Mango TV, each launching new series to attract viewers [1] - iQIYI has released series such as "Ling Jiang Xian" and "Shu Juan Yi Meng," while Tencent Video has responded with "Peach Blossom Reflecting the River" and "Sweep Drug Storm" [1] - The competition is not limited to domestic markets, as these platforms are expanding their reach globally, with significant growth in the export of Chinese dramas [3][4] Group 2 - The export value of Chinese dramas has seen substantial growth, reaching $8,274 million in 2022, a 45.6% increase from the previous year, and is expected to maintain a strong presence in the global market [3] - Over 40% of production companies are now collaborating directly with local media, while nearly 30% are using self-built international platforms to distribute content [3] - Tencent Video's WeTV has established a strong foothold in Southeast Asia, leveraging local partnerships and acquiring popular content to enhance its library [7][8] Group 3 - iQIYI has adopted a phased global strategy, initially acquiring exclusive rights to popular foreign content and then collaborating with local media for original productions [14] - Youku has focused on mature markets like Europe and North America, successfully distributing series like "White Night Chasing" and "The Longest Day in Chang'an" through platforms like Netflix [16] - Mango TV is exploring overseas markets primarily through variety shows, while gradually expanding its drama offerings [22] Group 4 - The content landscape is shifting from a focus on historical dramas to a more diverse range of genres, including contemporary and realistic themes, with 49% of exported dramas in 2023 being contemporary [25][27] - Platforms are increasingly investing in high-quality productions across various genres, with Tencent Video leveraging big IPs and high production values to create global hits [29][31] - iQIYI has developed a differentiated content matrix with various themed channels, successfully launching series that resonate with international audiences [33][35] Group 5 - The competition among platforms has evolved from simple content output to a more complex ecosystem involving platform development, technology integration, and cultural exchange [65] - The transition to a 3.0 phase signifies a shift towards collaborative ecosystem building, where platforms and content creators work together to enhance cultural influence globally [65]
信用债ETF的影响:市场的加速器
GOLDEN SUN SECURITIES· 2025-07-11 00:12
市场的加速器——信用债 ETF 的影响 今日概览 ◼ 重磅研报 【固定收益】市场的加速器——信用债 ETF 的影响——20250710 【海外】禾赛(HSAI.O)-赋能机器,感知世界——20250710 ◼ 研究视点 【电力设备】大金重工(002487.SZ)-业绩超预期,海风盈利提升—— 20250710 证券研究报告 | 朝闻国盛 gszqdatemark 2025 07 11 年 月 日 朝闻国盛 作者 | 分析师 张斌梅 | | | | | --- | --- | --- | --- | | 执业证书编号:S0680523070007 | | | | | 邮箱:zhangbinmei@gszq.com | | | | | 行业表现前五名 | | | | | 行业 | 1 月 | 3 月 | 1 年 | | 综合 | 9.8% | 19.7% | 72.9% | | 通信 | 9.0% | 22.7% | 33.3% | | 电力设备 | 8.7% | 15.5% | 31.8% | | 银行 | 8.4% | 20.4% | 36.5% | | 非银金融 | 7.9% | 14.0% | 47.2% ...
四大证券报精华摘要:7月11日
Zhong Guo Jin Rong Xin Xi Wang· 2025-07-11 00:05
Group 1 - The first two data center REITs have completed inquiries and will start subscriptions from July 14 to 15, indicating a growing market for REITs with quality assets [1] - The REITs market is expected to be further activated by the dual drive of "initial issuance + expansion" as relevant systems are optimized and the market matures [1] - High-net-worth individual investors have increasingly participated in ETF initial subscriptions, marking a shift from stock selection to index-based investment tools [1] Group 2 - As of July 9, 197 funds have ended fundraising early this year, with equity funds making up a significant portion, indicating a strong recovery in equity fund issuance [2] - The total issuance of newly established funds reached 5303.47 billion units in the first half of the year, with stock funds accounting for 35.46%, showing a substantial increase compared to the previous year [2] Group 3 - China's monetary policy has implemented moderate easing measures to support macroeconomic stability, achieving multiple goals such as growth stabilization and risk prevention [3] - The introduction of lithium supplement agents in the battery industry is gaining traction, with prices significantly higher than traditional materials, enhancing competitiveness for material companies [3] Group 4 - Global bank sector indices have seen significant increases, with the global index rising by 52% and the Chinese index by 59%, reflecting a revaluation of banks as stable assets [4] - The ongoing interest rate hikes in major economies have contributed to the attractiveness of banks, combining high shareholder returns with growth potential [4] Group 5 - The Hong Kong stock market has seen a surge in equity financing, nearing 3000 billion HKD, with IPOs showing remarkable growth, particularly in the technology and consumer sectors [5][6] - The market is characterized by a dual drive from technology and consumption, with significant activity in emerging consumer sectors and advanced technology fields [6] Group 6 - In 2024, 3667 A-share listed companies reported overseas business income, totaling 9.52 trillion yuan, a 56.58% increase from 2020, with manufacturing companies leading the growth [7] - Key sectors driving this growth include new energy vehicles, lithium batteries, and photovoltaics, highlighting the importance of industry chain and ecosystem expansion [7] Group 7 - As of July 9, the express delivery business in China has surpassed 1 trillion pieces, reflecting strong economic resilience and the growing scale of the consumer market [8] - The increase in express delivery volume is attributed to the rising e-commerce penetration and the expanding consumer market [8] Group 8 - Regulatory bodies have intensified oversight of delisted companies, with 19 companies receiving penalties this year, indicating a stricter regulatory environment [9]
中金2025下半年展望 | 电力设备+工控:传统赛道有韧性,关注新质生产力、核能、出海方向
中金点睛· 2025-07-10 23:31
中金研究 我们认为电网和工控行业2025年上半年基本面保持韧性,提示投资者关注下半年业绩和估值修复机会。 电网方面,1-5月国内电网投资保持高景气,特 高压核准节奏虽慢于预期但有望在三季度快速追赶,面临新能源消纳压力,我们认为全年以及未来两三年电网投资均有望保持向上趋势。工控方面, 1Q25以来部分行业需求持续改善,整体库存去化顺畅,但整体资本开支动能仍略显清淡,新周期有望窄幅波动。 此外,我们重点提示关注新质生产力 (AIDC+人形机器人)、核能复兴、出海三大投资方向。 投资主线1:关注新质生产力带来的盈利和估值弹性。 我们认为工控公司凭借电力电子的技术基础一方面向自动化、机器人领域延展,积极布局人形机器 人关节模组、核心零部件等产品带来了显著的估值弹性;另一方面向数据中心输配电领域延展,积极布局服务器电源、UPS、HVDC/巴拿马电源等,也充 分享受了AI资本开支上修的市场红利。 投资主线2:核能复兴,关注核电设备与SMR、可控核聚变赛道。 1H25国内核准10台核电机组,美国特朗普签署总统令复兴核能,我们认为核电作为重 要基荷能源,正重新回归全球各国视野,核能产业即将进入投资价值重估的战略复兴阶段。数据 ...
港股概念追踪 | 加快医药创新发展 多机构称2025年是中国创新药“出海”爆发年(附概念股)
智通财经网· 2025-07-10 23:25
智通财经APP获悉,中共中央政治局委员、国务院副总理刘国中10日到北京大学医学部调研医药创新发 展工作。他强调,要深入学习贯彻习近平总书记关于科技创新和卫生健康工作的重要指示精神,按照党 中央、国务院部署,面向人民生命健康,强化协同攻关和政策落实,加强医药领域基础研究和科技创新 能力建设,积极支持创新药和医疗器械加快发展,为推进健康中国建设提供有力支撑。相关概念股:基 石药业-B(02616)、和誉-B(02256)、和铂医药(02142)、信达生物(01801)。 刘国中还强调,要全链条强化政策保障,落实创新药融资、审评审批、入院使用和多元支付等政策,支 持引导商业健康保险发挥更大作用。要扩大高水平对外开放,深化医药技术国际交流合作,更好增进人 民健康福祉。各有关部门要加强协调、密切配合,健全政企沟通机制,及时回应相关诉求,营造良好发 展环境。 东吴证券指出医药行业三大核心驱动因素:高额BD交易持续落地;头部企业预计2025年扭亏,行业盈 利拐点将至;国内政策环境持续优化。 从资本市场来看:医药板块经历了4年的调整期,2025年至今板块迎来复苏,截至2025年5月30日,医药 生物行业涨跌幅位居申万31个一 ...
中国医药企业破浪扬帆加速全球化
Zhong Guo Chan Ye Jing Ji Xin Xi Wang· 2025-07-10 23:25
Core Viewpoint - The Chinese pharmaceutical industry is experiencing positive changes driven by policy optimization and innovation, with a focus on internationalization and high-quality development [2][3]. Group 1: Industry Development - China's pharmaceutical industry has become a global leader in the production of active pharmaceutical ingredients (APIs) and small to medium-sized medical devices, playing an increasingly important role in the global pharmaceutical landscape [1][2]. - The industry is transitioning from exporting intermediates and APIs to a comprehensive export of innovative products, marking a significant shift in the internationalization of Chinese pharmaceuticals [2][3]. Group 2: Policy and Regulatory Environment - Recent reforms in drug and medical device regulation have enhanced the safety and effectiveness of products while stimulating innovation within the industry [4][5]. - The acceleration of drug review and approval processes, along with China's membership in the International Council for Harmonisation (ICH), has created a "fast track" for innovative drugs to enter international markets [2][3]. Group 3: Market Strategies and Internationalization - Companies are encouraged to adopt differentiated and refined market entry strategies by analyzing regional market characteristics, disease profiles, payment capabilities, and competitive landscapes [3][4]. - Successful case studies highlight the importance of collaboration, local production, and building partnerships to penetrate target markets effectively [5]. Group 4: Challenges and Future Directions - Despite the progress, the industry faces various internal and external challenges that require modernization of the regulatory system and governance capabilities to ensure high-quality development [3][5]. - The industry must maintain confidence and focus on enhancing innovation capabilities and quality control to navigate complex international environments and competition [5].
财经观察:中国创新药“出海”有哪些看点?
Huan Qiu Shi Bao· 2025-07-10 22:53
【环球时报报道 记者 杨沙沙】编者的话:据美国《华尔街日报》等外媒报道,中国生物科技正迎 来"DeepSeek时刻"。今年以来,中国创新药企巨额"出海"BD(Business Development,商务拓展)交易 频现,其中沈阳三生制药5月宣布向辉瑞授予公司自主研发的突破性PD-1/VEGF双特异性抗体SSGJ-707 在全球(不包括中国内地)的开发、生产、商业化权利,其12.5亿美元首付款创下最高纪录。以前,中 国药企被认为"内卷"严重且缺乏创新性,但从去年年底至今,中国创新药企业出海BD形成了一个高 潮。从引进海外知识产权,到现在反向输出,中国创新药企引起全世界关注。中国从何时开始在制药领 域发力?目前处于哪个梯队?未来中国药企还有哪些增长点? " 有点像国产手机或是电动汽车 " 《华尔街日报》援引生物医药行业研究机构DealForma的数据说,2020年中国在5000万美元以上的医药 交易中占比不足5%,而到2024年这一比例已上升至近30%。 "这个比例非常可观。"位于硅谷的全球医药创新资本(H7 BioCapital)创始人及首席执行官李梦遥告诉 记者,包括信达、百济神州等中国药企,在海外布局成绩 ...
茶颜悦色以电商形式“出海” 布局北美零售业务
Sou Hu Cai Jing· 2025-07-10 20:52
中国商报(记者 贺阳)7月9日,茶颜悦色官方微信公众号正式官宣以电商形式向海外市场布局零售业务。中国商报记者从茶颜悦色了解到,茶颜悦色自建 Shopify独立站电商店铺,以及在亚马逊、TikTok Shop、沃尔玛、Weee、亚米网平台建立了品牌自营店铺,7月9日起陆续投入运营。 "很多朋友告诉我们,在海外某个城市看到了茶颜悦色的门店,或者是在海外商场买到了茶颜悦色的零售产品。虽然我们当下确实还没有到这些地方,同时 我们也在想,有没有什么好的方式能尽快到期待我们的海外朋友们身边,于是有了这次零售电商出海的尝试。"在提及零售电商出海原因时,茶颜悦色方面 表示。 "这几年,我们有同事和朋友在美国的旅行途中,都跟我们提到在美国的几个线上平台能买到茶颜的零售产品,这是挺有意思的信息。所以这次线上出海的 第一站,我们选择了美国。"茶颜悦色相关负责人说。 目前,茶颜悦色在湖南、湖北、江苏、重庆4地开设了近1000家线下直营门店(含子品牌)。作为一家成立于2013年的新茶饮品牌,茶颜悦色自2020年起打 造了零售产品线,聚焦茶叶与零食等高频复购品类,坚持主张线下到店消费,用"饮品+零售"的复购结构反向引流,吸引更多顾客到店 ...
产业拓链跨境并购上市公司描画出海新图谱
Zheng Quan Shi Bao· 2025-07-10 18:30
Core Insights - The "14th Five-Year Plan" period has seen a surge in Chinese companies going global, transitioning from "manufacturing exports" to "intelligent manufacturing exports" and from "single operations" to "industry chain collaboration" [1][2] - A total of 3,667 A-share listed companies disclosed overseas business income in 2024, accounting for 68% of A-share companies, with total overseas income reaching 9.52 trillion yuan, a 56.58% increase from 2020 [2] - Manufacturing companies have shown remarkable performance, with overseas income reaching 6.39 trillion yuan in 2024, a 75.42% increase from 2020 [2] Industry Performance - The new growth drivers in foreign trade include new energy vehicles, lithium batteries, and photovoltaics, with companies like Great Wall Motors and Changan Automobile seeing over 600% growth in overseas income compared to 2020 [3] - CATL's overseas income reached 110.34 billion yuan in 2024, growing over 14 times since 2020, with significant investments in Indonesia [3] - The engineering machinery sector has seen overseas income share rise from 11.38% in 2020 to 47.48% in 2024, with major companies like SANY Heavy Industry and Zoomlion contributing over half of their revenue from overseas [3] Strategic Trends - The trend of "industrial chain going overseas" and "ecosystem going overseas" has become prominent, with leading companies enhancing efficiency by leveraging their chain advantages [4] - ASEAN has become China's largest export market, with significant investments in production capacity in Southeast Asia, such as Changan Automobile's new energy vehicle base in Thailand [4] - Latin America is emerging as a new growth area, with companies like BYD and Linglong Tire making substantial investments in Brazil [5] Cross-Border M&A Activity - Cross-border mergers and acquisitions (M&A) have seen a resurgence, with 216 disclosed cases in 2024, a 32.52% increase year-on-year, marking a five-year high [6] - M&A activities are categorized into three types: acquiring overseas brands, core technology acquisition, and channel acquisition, with significant examples in advanced manufacturing and biomedicine [6] Capital Market Developments - In 2025, leading companies in hard technology are accelerating their overseas strategies, with over 50 A-share companies announcing plans to list in Hong Kong [7] - Notable companies like CATL and Hengrui Medicine have successfully listed in Hong Kong, with CATL raising 35.3 billion HKD, the largest IPO globally for the year [7] Future Outlook - Industry experts express optimism about the future of Chinese companies going global, highlighting opportunities in green exports, capacity expansion, and infrastructure projects [10] - The focus on protecting national security and intellectual property while targeting high-end markets is emphasized for companies in high-tech sectors [10]